{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:12:41Z","timestamp":1789956761906,"version":"4.0.1"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,2,7]]},"DOI":"10.18632\/oncotarget.14216","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T19:28:23Z","timestamp":1482866903000},"page":"9794-9805","source":"Crossref","is-referenced-by-count":23,"title":["Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Bingshu","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"He","sequence":"additional","affiliation":[{"name":"Department of Medical Records, Harbin Medical University Cancer Hospital, Harbin, 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung","family":"Vu","sequence":"additional","affiliation":[{"name":"Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas, 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas, 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China"},{"name":"Heilongjiang Academy of Medical Sciences, Heilongjiang Province, Harbin, 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","article-title":"DNA methylation in cancer: too much, but also too little","volume":"21","author":"Ehrlich","year":"2002","journal-title":"Oncogene"},{"key":"2","first-page":"1009","article-title":"Genetic alteration mapping on chromosome 7 in primary breast cancer","volume":"3","author":"Lidereau","year":"1997","journal-title":"Clin Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2826","article-title":"The Hox genes and their roles in oncogenesis","volume":"10","author":"Sukumar","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"4","first-page":"673","article-title":"Aberrant expression of HOX genes in human invasive breast carcinoma","volume":"13","author":"Katoh","year":"2005","journal-title":"Oncol Rep"},{"key":"5","first-page":"64","article-title":"Analysis of HOX Gene Expression Patterns in Human Breast Cancer","volume":"56","author":"Kim","year":"2013","journal-title":"Mol Biotechnol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1242\/dev.121.5.1373","article-title":"Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility","volume":"121","author":"Potter","year":"1995","journal-title":"Development"},{"key":"7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ijc.23563","article-title":"HOXA11DNA methylation-A novel prognostic biomarker in ovarian cancer","volume":"123","author":"Widschwendter","year":"2008","journal-title":"Int J Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.18632\/oncotarget.1464","article-title":"HOXA11 hypermethylation is associated with progression of non-small cell lung cancer","volume":"4","author":"Kim","year":"2013","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12935-014-0079-7","article-title":"HOXA11 gene is hypermethylation and aberrant expression in gastric cancer","volume":"14","author":"Ji","year":"2014","journal-title":"Cancer Cell Int"},{"key":"10","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1158\/0008-5472.CAN-06-2761","article-title":"Epigenetic inactivation of the HOXA gene cluster in breast cancer","volume":"66","author":"Futscher","year":"2006","journal-title":"Cancer Res"},{"key":"11","first-page":"41","article-title":"A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues","volume":"5","author":"Evron","year":"2014","journal-title":"Epigenetics"},{"key":"12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11060-013-1133-3","article-title":"Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma","volume":"113","author":"Tama\u0161auskas","year":"2013","journal-title":"J Neurooncol"},{"key":"13","first-page":"1050","article-title":"HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse","volume":"118","author":"Taylor","year":"2008","journal-title":"J Clin Invest"},{"key":"14","first-page":"1129","article-title":"Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium","volume":"84","author":"Arici","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"15","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/jcem.87.6.8527","article-title":"HOXA11 silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium","volume":"87","author":"Taylor","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molonc.2010.11.004","article-title":"Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer","volume":"5","author":"Tost","year":"2011","journal-title":"Mol Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molonc.2010.11.002","article-title":"DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables","volume":"5","author":"Rotti","year":"2011","journal-title":"Mol Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13058-014-0450-6","article-title":"DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival","volume":"16","author":"Millikan","year":"2014","journal-title":"Breast Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1158\/1078-0432.CCR-04-0597","article-title":"Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients","volume":"10","author":"Cairns","year":"2004","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev"},{"key":"21","first-page":"2277","article-title":"Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma","volume":"9","author":"Goodfellow","year":"2003","journal-title":"Clin Cancer Res"},{"key":"22","first-page":"201","article-title":"Epigenetic changes and functional study of HOXA11 in human gastric cancer","volume":"20157","author":"Guo","journal-title":"Epigenomics"},{"key":"23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Kurman","year":"2011","journal-title":"Mod Pathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11010-010-0473-y","article-title":"Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents","volume":"342","author":"Ralhan","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/jcmm.12448","article-title":"MicroRNA-30d and microRNA-181a regulate HOXA11 expression in the uterosacral ligaments and are overexpressed in pelvic organ prolapse","volume":"19","author":"Bai","year":"2015","journal-title":"J Cell Mol Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/emmm.201100122","article-title":"ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium","volume":"3","author":"Menon","year":"2011","journal-title":"EMBO Mol Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ccr.2005.08.006","article-title":"Of Snail, mice, and women","volume":"8","author":"Sukumar","year":"2005","journal-title":"Cancer Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Love","year":"2010","journal-title":"J Clin Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Pegram","year":"2007","journal-title":"J Clin Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp391","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Nielsen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0780-8","article-title":"Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer","volume":"120","author":"Lee","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"32","first-page":"1736","article-title":"Senn H-JPanel members. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St","author":"Th\u00fcrlimann","year":"2011","journal-title":"Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","article-title":"MethyLight: a high-throughput assay to measure DNA methylation","volume":"28","author":"Laird","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"key":"35","first-page":"2231","article-title":"Methylation of HACE1 in gastric carcinoma","volume":"29","author":"Hibi","year":"2009","journal-title":"Anticancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"18485","DOI":"10.18632\/oncotarget.7608","article-title":"Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer","volume":"14","author":"Pang","year":"2016","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Baylin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"38","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/sj.onc.1206545","article-title":"Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression","volume":"22","author":"Futscher","year":"2003","journal-title":"Oncogene"},{"key":"39","doi-asserted-by":"crossref","first-page":"e6845","DOI":"10.1371\/journal.pone.0006845","article-title":"HoxA-11 and FOXO1A Cooperate to Regulate Decidual Prolactin Expression: Towards Inferring the Core Transcriptional Regulators of Decidual Genes","volume":"4","author":"Wagner","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T02:08:39Z","timestamp":1658282919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,25]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,7]]}},"alternative-id":["14216","28038461"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14216","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,25]]}}}